Table of Contents Author Guidelines Submit a Manuscript
Bioinorganic Chemistry and Applications
Volume 2016, Article ID 7010519, 11 pages
http://dx.doi.org/10.1155/2016/7010519
Research Article

Chemical Species, Micromorphology, and XRD Fingerprint Analysis of Tibetan Medicine Zuotai Containing Mercury

1Pharmacology and Safety Evaluation Key Laboratory of Tibetan Medicine in Qinghai Province, Northwest Institute of Plateau Biology, Chinese Academy of Sciences, Xining, Qinghai 810008, China
2Key Laboratory of Tibetan Medicine Research, Chinese Academy of Sciences, Xining, Qinghai 810008, China
3Tibetan Traditional Medical College, Lhasa, Tibet 850000, China
4Gansu Province Academy of Tibetan Medicine, Hezuo, Gansu 747000, China
5Aba Prefecture Tibetan Medicine Hospital, Maerkang, Sichuan 624000, China
6Qinghai Province Tibetan Medicine Hospital, Xining, Qinghai 810007, China

Received 20 March 2016; Accepted 4 July 2016

Academic Editor: Patrick J. Bednarski

Copyright © 2016 Cen Li et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Xiang-duo Li-xian-jia and B.-F. Luo, “New explore on the origin of Tibetan Medicine,” China Journal of Medical History, vol. 32, no. 3, pp. 188–191, 2002. View at Google Scholar
  2. Zong-ke Yang-zheng-gang-bu, “The Tibetan medicine conditions in the times of Tibetan tribes-countries,” Tibetan Studies, vol. 4, pp. 85–96, 1996. View at Google Scholar
  3. Y. Zhen, “The initial analysis on Tibetan medicine origin,” Journal of Medicine & Pharmacy of Chinese Minorities, vol. 7, no. 2, pp. 39–40, 2001. View at Google Scholar
  4. Lan-ke, “The simple discussion of Tibetan medicine Zuota,” Journal of Medicine & Pharmacy of Chinese Minorities, vol. 5, supplement, article 86, 1995. View at Google Scholar
  5. Suo-lang, “The processing of Zuota,” Journal of Medicine & Pharmacy of Chinese Minorities, vol. 5, p. 40, 2007. View at Google Scholar
  6. Z. Wang, “The reinterpreting of Tibetan medicine essence ‘Zuota’,” Health Word (Academic Edition), vol. 4, no. 9, pp. 84–85, 2010. View at Google Scholar
  7. Ban-ma-cai-ren, “Discussing the processing technology of Zuota from the perspective of chemistry,” Journal of Medicine & Pharmacy of Chinese Minorities, vol. 7, pp. 62–63, 2013. View at Google Scholar
  8. Ga-ma-qu-pei, Tu-deng-ge-sang, and Ge-qiong, “The processing method of Mercury medicinal powder (Zuotai),” China, Patent, 88107006.8, 1988.
  9. Kan-zhao-ben, “An introduction of Zuotai in Tibetan patent medicine,” China Journal of Chinese Materia Medica, vol. 38, no. 10, pp. 1621–1623, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Li, Leng-beng-cai-rang, Suo-lang, Gong-bu-dong-zhi, Y.-Z. Du, and L.-X. Wei, “The chemical and structural analysis of Tibetan medicine Fanshi,” Spectroscopy and Spectral Analysis, vol. 32, no. 1, pp. 248–251, 2012. View at Google Scholar
  11. Dou-ga, “The toxicity evaluation of Tibetan medicine Zuotai and its compound preparations,” Journal of Qinghai Junior Teachers's College (Education Sciences Edition), vol. 4, pp. 72–75, 2005. View at Google Scholar
  12. Yu-tuo Yuan-dan-gong-bu, Si Bu Yi Dian (Four Medical Codes), Shanghai Science and Technology Press, Shanghai, China, 1987.
  13. B.-S. Yang, Jiang-ji-cun, Jiang-yong et al., “The effect characteristics of mercury and safety evaluation Tibetan medicine Zuota,” Tibetan Studies, vol. 1, pp. 74–79, 2004. View at Google Scholar
  14. G.-Y. Zhang, D.-P. Wang, C. Li, H.-M. Zhu, L.-X. Wei, and Y.-Z. Du, “The chronic accumulation of mercury in Tibetan Medicine Zuotai (gTso thal),” Lishizhen Medcine and Material Medica Research, vol. 23, no. 9, pp. 2146–2147, 2012. View at Google Scholar
  15. H.-M. Zhu, L.-X. Wei, Y.-Z. Du, D.-P. Wang, and C. Li, “Preliminary study on the toxicity in mice of Tibetan Medicine Zuotai under chronic administration,” Lishizhen Medcine and Material Medica Research, vol. 24, no. 8, pp. 2022–2024, 2013. View at Google Scholar
  16. C. Li, D.-P. Wang, Duo-jie et al., “Non-clinical safety evaluation of tibetan medicine zuotai and preliminary clinical safety study of its compound preparation dangzuo,” China Journal of Chinese Materia Medica, vol. 39, no. 13, pp. 2573–2582, 2014. View at Google Scholar
  17. Y. Zeng, S.-M. He, Y. Liu, and Y. Zhang, “Portion study on the central nervous pharmacology effects of Tibetan medicine Zuota,” Journal of Sichuan of Traditional Chinese Medicine, vol. 23, no. 11, pp. 33–34, 2005. View at Google Scholar
  18. E.-N. Jiang, C.-G. Zhang, J.-H. Wang et al., “The study on the main pharmacodynamic actions of Tibetan Medicine Zuotai,” Lishizhen Medcine and Material Medica Research, vol. 20, no. 8, pp. 3–4, 2009. View at Google Scholar
  19. Sang-ji-duo-jie and Gong-ga-luo-bu, “Quality control methods and new usage of a kind of the product processed Tibetan medicine,” China, Patent, 200810093949.5, 2008.
  20. Z.-J. Chen, X.-L. Pu, W.-H. Li, K.-Z. Wu, G.-W. Lan, and J. Cui, “The influence on Drosophila life of Tibetan medicine Zuota,” Lishizhen Medcine and Material Medica Research, vol. 22, no. 2, pp. 422–423, 2011. View at Google Scholar
  21. T. Zhu, B. Shen, X.-W. Wang, Bian-ba-chi-ren, and G. Yao, “The proliferation of 239 cell promoted by Tibetan Medicine Zuotai through caspase-3,” Journal of Medicine & Pharmacy of Chinese Minorities, vol. 5, pp. 47–49, 2013. View at Google Scholar
  22. Environmental Protection Agency (EPA), “Tocicological review of hexavalent chromium,” in Support of Summary Information on the Integrated Risk Information System (IRIS), EPA, Washington, DC, USA, 1998. View at Google Scholar
  23. Centers for Disease Control and Prevention (CDC), Chromium Toxicity, Agency for Toxic Substances and Disease Registry Case Studies in Environmental Medicine (CSEM), Course: WB 1466, Original Date: December 18, 2008, Expiration Date: December 18, 2011, http://www.atsdr.cdc.gov/csem/chromium/docs/chromium.pdf.
  24. A. D. Dayan and A. J. Paine, “Mechanisms of chromium toxicity, carcinogenicity and allergenicity: review of the literature from 1985 to 2000,” Human & Experimental Toxicology, vol. 20, no. 9, pp. 439–451, 2001. View at Publisher · View at Google Scholar · View at Scopus
  25. J. B. Vincent, “Chromium: is it essential, pharmacologically relevant, or toxic?” Metal Ions in Life Sciences, vol. 13, pp. 171–198, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. L.-F. Yan, “Analysis on the microstructure and chemical components of Tibetan medicine Zuotai,” China Tibetology, vol. 3, pp. 150–174, 2007. View at Google Scholar
  27. L.-F. Yan and X.-K. Ma, “Chemical structure analysis on the carbon in Tibetan medicine Zuotai,” Chinese Journal of Ethnomedicine and Ethnopharmacy, vol. 9, pp. 1–2, 2010. View at Google Scholar
  28. G.-W. Lan, Z.-J. Chen, W.-H. Li, K.-Z. Wu, J. Cui, and X.-L. Piao, “Analysis on chemical constituents of Tibetan Medicine Zogta,” Lishizhen Medcine and Material Medica Research, vol. 21, no. 12, pp. 3209–3211, 2010. View at Google Scholar
  29. X.-Y. Zhao, M. Sun, J.-X. Wang et al., “Characterization of Tibetan medicine Zuota by multiple techniques,” Bioinorganic Chemistry and Applications, vol. 2013, Article ID 198545, 11 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. H. M. Mansour, Y.-S. Rhee, and X. Wu, “Nanomedicine in pulmonary delivery,” International Journal of Nanomedicine, vol. 4, pp. 299–319, 2009. View at Google Scholar · View at Scopus
  31. J. C. Sung, B. L. Pulliam, and D. A. Edwards, “Nanoparticles for drug delivery to the lungs,” Trends in Biotechnology, vol. 25, no. 12, pp. 563–570, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. I. Brigger, C. Dubernet, and P. Couvreur, “Nanoparticles in cancer therapy and diagnosis,” Advanced Drug Delivery Reviews, vol. 54, no. 5, pp. 631–651, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. S. B. Tiwari and M. M. Amiji, “A review of nanocarrier-based CNS delivery systems,” Current Drug Delivery, vol. 3, no. 2, pp. 219–232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. I. P. Kaur, R. Bhandari, S. Bhandari, and V. Kakkar, “Potential of solid lipid nanoparticles in brain targeting,” Journal of Controlled Release, vol. 127, no. 2, pp. 97–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. S.-F. Cao and Y.-Q. Liang, “Thermodynamics analysis of the mercuric sulfide dissolved in aqua regia,” Journal of Southwest Institute of Technology, vol. 14, no. 1, pp. 71–73, 1999. View at Google Scholar
  36. R. A. Bernhoft, “Mercury toxicity and treatment: a review of the literature,” Journal of Environmental and Public Health, vol. 2012, Article ID 460508, 10 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Liu, J.-Z. Shi, L.-M. Yu, R. A. Goyer, and M. P. Waalkes, “Mercury in traditional medicines: is cinnabar toxicologically similar to common mercurials?” Experimental Biology and Medicine, vol. 233, no. 7, pp. 810–817, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. H.-X. Gao, Multivariate Statistical Analysis of Application, Beijing University Press, Beijing, China, 2005.
  39. X.-S. Fu, X.-H. Liu, R.-C. Lin et al., “X-ray diffraction fourier fingerprint of magnetitum,” Chinese Traditional Patent Medicine, vol. 33, no. 10, pp. 1652–1657, 2011. View at Google Scholar
  40. L.-Y. Xia, S.-G. Shen, Z.-H. Liu, and H.-W. Sun, “Identification of geographical origins of rice with pattern recognition technique by near infrared spectroscopy,” Spectroscopy and Spectral Analysis, vol. 33, no. 1, pp. 102–105, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. J. Wu, F.-R. Huang, C.-H. Huang, J. Zhang, and X.-D. Chen, “Study on near infrared spectroscopy of transgenic soybean identification based on principal component analysis and neural network,” Spectroscopy and Spectral Analysis, vol. 33, no. 6, pp. 1537–1541, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. Y. Yang and Z.-F. Guan, “Study on the traditional Tibetan medicine and its processing technology,” Journal of MinZu University of China (Natural Sciences Edition), vol. 17, no. 3, p. 83, 2008. View at Google Scholar
  43. D.-P. Wang, L.-X. Wei, Y.-Z. Du et al., “Study on the method of determination of mercury sulfide in Tibetan Medicine GTso Thal,” Lishizhen Medcine and Material Medica Research, vol. 21, no. 8, pp. 1359–1361, 2010. View at Google Scholar
  44. B.-C. Zhang, M. Peng, P.-J. Guo et al., Research Report of National Tibetan Medicine Development Strategy, Sichuan Science and Technology Press, Sichuan, China, 2003.
  45. S. Zhang, “The comparing between the mercury processing technologies of Hu Guzi and Wujianba.Renqingbei,” The Chinese Pharmaceutical Journal, vol. 34, no. 12, pp. 849–850, 1999. View at Google Scholar
  46. P. C. Ray, The History of Hindu Chemistry, vol. 1, The Bengal Chemical & Pharmaceutical Works, Calcutta, India, 2nd edition, 1956.
  47. http://www.ihchina.cn/show/feiyiweb/html/com.tjopen.define.pojo.feiyiwangzhan.GuoJiaMingLu.detail.html?id=b4b76369-14b8-498c-ba47-bcc8254c5948&classPath=com.tjopen.define.pojo.feiyiweb.guojiaminglu.GuoJiaMingLu.
  48. K. Y. Win and S.-S. Feng, “Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs,” Biomaterials, vol. 26, no. 15, pp. 2713–2722, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Jung, W. Kamm, A. Breitenbach, E. Kaiserling, J. X. Xiao, and T. Kissel, “Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?” European Journal of Pharmaceutics and Biopharmaceutics, vol. 50, no. 1, pp. 147–160, 2000. View at Publisher · View at Google Scholar · View at Scopus
  50. C. Li, Duo-ji, Zhan-dui, Z.-J. Xia, Y.-Z. Du, and L.-X. Wei, “Chemical and structural analysis of Nengchi Bajin ashes in refining of Tibetan medicine gTSo thal,” China Journal of Chinese Materia Medica, vol. 37, no. 13, pp. 1952–1957, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. C. Li, Suo-lang, Ze-ge, Z. Wang, Y.-Z. Du, and L.-X. Wei, “Chemical and structural analysis of Nengchi Bakuang ashes in refining of Tibetan medicine Zuotai,” Chinese Journal of Pharmaceutical Analysis, vol. 31, no. 12, pp. 2220–2224, 2011. View at Google Scholar